Close
Almac
Achema middle east

Drug Research

Targeted Drug Mix For Ovarian Cancer Cases Twice Effective

A targeted drug combination for patients suffering from an ovarian cancer type can be nearly twice as effective as the next-best treatment, according to preliminary results from a Phase II study. Researchers opine that these results, which happen to be...

Diosynvax Offers Lasting Defense Against COVID-19 Variants

Researchers have created a novel Covid-19 vaccine called DIOSynVax that can be administered using air-jet technology rather than a needle. This revolutionary vaccine aims to provide long-lasting protection against not only SARS-CoV-2 but also other related diseases. Traditionally, the body's...

Overactive Protein Responsible For Severe Skin Disorder

A significant breakthrough has been made by researchers from the National Institutes of Health (NIH) in collaboration with scientists from the University of California San Diego (UCSD) and the University of Pittsburgh in understanding and potentially treating a rare...

New Drug Extends Treatment Duration For Glioma Patients

The University of California scientists have discovered a new targeted therapy drug that can extend the treatment duration for individuals with a specific subtype of glioma, a deadly brain tumor. The drug, vorasidenib, was found to more than double...

Innovative Partnership For RNA Medicine Delivery Solutions

The Centre for Process Innovation (CPI) plans to establish a new Intracellular Drug Delivery Centre in the UK to develop innovative lipid nanoparticle (LNP) formulations for delivering RNA-based medicines. This partnership, funded by a £10 million grant from Innovate...

Sterling Joins Partnership to Advance AI Flow Chemistry Techniques

Sterling Pharma Solutions will join a consortium of leading industrial innovators from across the chemical industry supply chain to accelerate the use of continuous manufacturing in a range of industries, with digitalization at its core. The partnership, expected to last...

ASM Research Chemicals Launches Development Packs for API Manufacturing

ASM Research Chemicals, a contract research and development services provider specialized in organic chemistry, is launching its new development pack (DevPack) service intended for active pharmaceutical ingredients (APIs) manufacturing. The service was developed and optimized across ten core partners to...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »